Well Referenced

Tag: relapse prediction

Utility of faecal calprotectin analysis in adult inflammatory bowel disease

This study explores the use of faecal calprotectin (FC) measurement as a non-invasive biomarker for diagnosing and managing inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC). Elevated FC levels correlate with active disease and can help distinguish IBD from other gastrointestinal conditions like irritable bowel syndrome

Read More »
June 26, 2025 No Comments

Faecal calprotectin — a useful tool in the management of inflammatory bowel disease

This review highlights the role of faecal calprotectin as a non-invasive biomarker in managing inflammatory bowel disease (IBD). Elevated faecal calprotectin levels reliably differentiate IBD from non-inflammatory gastrointestinal disorders, correlate with disease activity assessed via endoscopy and histology, and predict relapse within 12 months for patients in clinical remission. While

Read More »
June 26, 2025 No Comments